This week, a #databreach was disclosed by #23andMe, affecting 6.9 million users and compromising their #genetics data information. The incident rai

Guest Istvan Fekete discusses what large academic medical institutions are responsible for that sponsors and other commercial entities are generally n

In this video,, the focus is on the growing interest in digital engagement programs among FDA-regulated companies, but it also addresses the concerns

Jessica Thompson discusses how project management can be a game-changer in clinical research. We talk about how poor project management can lead to d

A conversation with Dan Sfera on the changes in diversity requirements as we begin to perform clinical research

On September 5th, 2023, a Miami jury found a medical clinic owner and pharmacist guilty of falsifying and fabricating clinical trial data. We highli

In this episode of the DarshanTalks Podcast, host Darshan Kulkarni Pharm.D, MS, Esq. welcomes Biopharma Medical Affairs expert, Irene von Hennigs, Pha

In today’s episode of DarshanTalks Podcast, host Darshan Kulkarni welcomes guest Patti Zettler to talk about the non-therapeutic uses of drugs and d

The Office of Inspector General (OIG) recently announced that #cme is under special scrutiny. They gave an advisory opinion based on a request they h